These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 23431367

  • 1. Regression of albuminuria and hypertension and arrest of severe renal injury by a losartan-hydrochlorothiazide association in a model of very advanced nephropathy.
    Arias SC, Valente CP, Machado FG, Fanelli C, Origassa CS, de Brito T, Camara NO, Malheiros DM, Zatz R, Fujihara CK.
    PLoS One; 2013; 8(2):e56215. PubMed ID: 23431367
    [Abstract] [Full Text] [Related]

  • 2. An association of losartan-hydrochlorothiazide, but not losartan-furosemide, completely arrests progressive injury in the remnant kidney.
    Arias SC, Souza RA, Malheiros DM, Fanelli C, Fujihara CK, Zatz R.
    Am J Physiol Renal Physiol; 2016 Jan 15; 310(2):F135-43. PubMed ID: 26538442
    [Abstract] [Full Text] [Related]

  • 3. Losartan-hydrochlorothiazide association promotes lasting blood pressure normalization and completely arrests long-term renal injury in the 5/6 ablation model.
    Fujihara CK, Malheiros DM, Zatz R.
    Am J Physiol Renal Physiol; 2007 Jun 15; 292(6):F1810-8. PubMed ID: 17344184
    [Abstract] [Full Text] [Related]

  • 4. A Novel Aldosterone Antagonist Limits Renal Injury in 5/6 Nephrectomy.
    Fujihara CK, Kowala MC, Breyer MD, Sena CR, Rodrigues MV, Arias SCA, Fanelli C, Malheiros DM, Jadhav PK, Montrose-Rafizadeh C, Krieger JE, Zatz R.
    Sci Rep; 2017 Aug 11; 7(1):7899. PubMed ID: 28801620
    [Abstract] [Full Text] [Related]

  • 5. Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory.
    Gonçalves AR, Fujihara CK, Mattar AL, Malheiros DM, Noronha Ide L, de Nucci G, Zatz R.
    Am J Physiol Renal Physiol; 2004 May 11; 286(5):F945-54. PubMed ID: 15075190
    [Abstract] [Full Text] [Related]

  • 6. An extremely high dose of losartan affords superior renoprotection in the remnant model.
    Fujihara CK, Velho M, Malheiros DM, Zatz R.
    Kidney Int; 2005 May 11; 67(5):1913-24. PubMed ID: 15840039
    [Abstract] [Full Text] [Related]

  • 7. Combined mycophenolate mofetil and losartan therapy arrests established injury in the remnant kidney.
    Fujihara CK, DE Lourdes Noronha I, Malheiros DMAC, Antunes GR, DE Oliveira IB, Zatz R.
    J Am Soc Nephrol; 2000 Feb 11; 11(2):283-290. PubMed ID: 10665935
    [Abstract] [Full Text] [Related]

  • 8. Early brief treatment with losartan plus mycophenolate mofetil provides lasting renoprotection in a renal ablation model.
    Fujihara CK, Vieira JM, Sena CR, Ventura BH, Malheiros DM, Zatz R.
    Am J Nephrol; 2010 Feb 11; 32(2):95-102. PubMed ID: 20551627
    [Abstract] [Full Text] [Related]

  • 9. Effects of losartan, in monotherapy or in association with hydrochlorothiazide, in chronic nephropathy resulting from losartan treatment during lactation.
    Fanelli C, Fernandes BH, Machado FG, Okabe C, Malheiros DM, Fujihara CK, Zatz R.
    Am J Physiol Renal Physiol; 2011 Sep 11; 301(3):F580-7. PubMed ID: 21653629
    [Abstract] [Full Text] [Related]

  • 10. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
    Kujal P, Chábová VČ, Vernerová Z, Walkowska A, Kompanowska-Jezierska E, Sadowski J, Vaňourková Z, Husková Z, Opočenský M, Skaroupková P, Schejbalová S, Kramer HJ, Rakušan D, Malý J, Netuka I, Vaněčková I, Kopkan L, Cervenka L.
    Clin Exp Pharmacol Physiol; 2010 Dec 11; 37(12):1159-69. PubMed ID: 20880190
    [Abstract] [Full Text] [Related]

  • 11. L/N-type calcium channel blocker cilnidipine reduces plasma aldosterone, albuminuria, and urinary liver-type fatty acid binding protein in patients with chronic kidney disease.
    Abe M, Maruyama N, Suzuki H, Inoshita A, Yoshida Y, Okada K, Soma M.
    Heart Vessels; 2013 Jul 11; 28(4):480-9. PubMed ID: 22914905
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. NLRP3 inflammasome inhibition ameliorates tubulointerstitial injury in the remnant kidney model.
    Foresto-Neto O, Ávila VF, Arias SCA, Zambom FFF, Rempel LCT, Faustino VD, Machado FG, Malheiros DMAC, Abensur H, Camara NOS, Zatz R, Fujihara CK.
    Lab Invest; 2018 Jun 11; 98(6):773-782. PubMed ID: 29511302
    [Abstract] [Full Text] [Related]

  • 15. Effects of Single and Combined Losartan and Tempol Treatments on Oxidative Stress, Kidney Structure and Function in Spontaneously Hypertensive Rats with Early Course of Proteinuric Nephropathy.
    Karanovic D, Grujic-Milanovic J, Miloradovic Z, Ivanov M, Jovovic D, Vajic UJ, Zivotic M, Markovic-Lipkovski J, Mihailovic-Stanojevic N.
    PLoS One; 2016 Jun 11; 11(8):e0161706. PubMed ID: 27560781
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Metformin arrests the progression of established kidney disease in the subtotal nephrectomy model of chronic kidney disease.
    Borges CM, Fujihara CK, Malheiros DMAC, de Ávila VF, Formigari GP, Lopes de Faria JB.
    Am J Physiol Renal Physiol; 2020 May 01; 318(5):F1229-F1236. PubMed ID: 32249610
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease.
    Dilauro M, Zimpelmann J, Robertson SJ, Genest D, Burns KD.
    Am J Physiol Renal Physiol; 2010 Jun 01; 298(6):F1523-32. PubMed ID: 20357030
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.